
Options for treating premenstrual dysphoric disorder, from the Harvard Mental Health Letter
October 2009
Many women have premenstrual syndrome, a wide range of physical or emotional symptoms that occur before the monthly menstrual cycle. For about 5% of women of childbearing age, though, the symptoms are so severe that they cause significant mental distress and interfere with work, school, or relationships. This is called premenstrual dysphoric disorder (PMDD). Although sometimes dismissed as trivial, PMDD can disrupt a woman’s life so much that she may consider suicide. Fortunately, treatment options exist for PMDD, reports the October 2009 issue of the Harvard Mental Health Letter.
Antidepressants that slow the reuptake of serotonin, a brain chemical involved in mood, are effective for many women with PMDD. Options include selective serotonin reuptake inhibitors (SSRIs) such as citalopram (Celexa) and fluoxetine (Prozac); venlafaxine (Effexor), a serotonin and norepinephrine reuptake inhibitor (SNRI); and clomipramine (Anafranil), a tricyclic antidepressant that has a strong effect on serotonin. These drugs work on PMDD more quickly than on depression, so women don’t necessarily have to take them every day. Instead, the drugs can be taken for the 14-day span that begins just after ovulation and ends with menstruation.
Although progesterone supplements are often prescribed for PMDD, there is no evidence that low levels of this hormone contribute to the disorder. Largely because of side effects, hormone therapy strategies such as oral contraceptives, estrogen, and gonadotropin-releasing hormone agonists are considered second-line treatments for PMDD.
Lifestyle changes and psychotherapies have not been well studied in PMDD, but a few have shown promise, notes Dr. Michael Miller, editor in chief of the Harvard Mental Health Letter. In particular, consuming more high-protein foods or complex carbohydrates raises levels of tryptophan, which helps modulate mood. Engaging in regular aerobic physical activity also tends to improve mood and energy levels.
Read the full-length article: "Treating premenstrual dysphoric disorder"
Also in this issue of the Harvard Mental Health Letter
- References for "Infection, inflammation, and mental illness"
- References for "Treating premenstrual dysphoric disorder"
- References for "Lithium-induced kidney problems"
- References for "Questions & answers: Preventing post-traumatic stress disorder"
- Infection, inflammation, and mental illness
- Treating premenstrual dysphoric disorder
- Lithium-induced kidney problems
- In Brief: Drug fails to subdue repetitive behavior in children with autism spectrum disorders
- In Brief: Supplement may ease compulsive hair pulling
- Questions & answers
- Correction to "Treating premenstrual dysphoric disorder"
More Harvard Health News »
About Harvard Health Publications
Harvard Health Publications publishes four monthly newsletters--Harvard Health Letter, Harvard Women's Health Watch, Harvard Men's Health Watch, and Harvard Heart Letter--as well as more than 50 special health reports and books drawing on the expertise of the 8,000 faculty physicians at Harvard Medical School and its world-famous affiliated hospitals.
